{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T04:16:21Z","timestamp":1750306581668,"version":"3.41.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:00:00Z","timestamp":1750204800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:00:00Z","timestamp":1750204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Medical Research Foundation of Guangdong Province","award":["A2021244"],"award-info":[{"award-number":["A2021244"]}]},{"name":"the Science and Technology Special Project of Guangdong Province","award":["2019ST022, STKJ2021060","2019ST022, STKJ2021060"],"award-info":[{"award-number":["2019ST022, STKJ2021060","2019ST022, STKJ2021060"]}]},{"name":"the Science and Technology Planning Project of Shantou, China","award":["200604125265614"],"award-info":[{"award-number":["200604125265614"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hereditas"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>This study aimed to evaluate the prognostic significance of epithelial zinc finger protein (EZF\/KLF4) in lung adenocarcinoma (LAC) and explore its potential roles in tumor progression and immune regulation.\n<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods and Materials<\/jats:title>\n            <jats:p>EZF expression and its associations with clinical characteristics were analyzed using TCGA and GEO datasets, and validated by immunohistochemistry in 25 paired LAC and adjacent normal tissues. Mechanistic insights were investigated through protein\u2013protein interaction networks, gene set enrichment analysis (GSEA), DNA methylation profiling, and immune cell infiltration analysis via single-sample GSEA. A prognostic nomogram incorporating EZF expression, pT and pN stages, and residual tumor status was constructed using Cox regression modeling.\n<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>EZF expression was significantly downregulated in LAC tissues compared to normal tissues across multiple cohorts (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001), yet paradoxically associated with advanced tumor stages and worse overall, disease-specific, and progression-free survival. Functional analyses revealed EZF-associated pathways enriched in immune modulation. EZF expression correlated strongly with infiltrating immune cells, including NK cells, eosinophils, mast cells, and neutrophils. Hypomethylation of the EZF promoter was linked to poor prognosis. The constructed nomogram exhibited strong predictive accuracy for patient outcomes.\n<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>EZF functions as a context-dependent regulator in LAC and may act as a prognostic biomarker by modulating tumor-immune interactions. These findings offer novel insights into the integration of molecular and immune features for personalized risk stratification and therapeutic guidance in LAC.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s41065-025-00476-7","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T06:15:48Z","timestamp":1750227348000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Epithelial zinc finger protein in lung adenocarcinoma: prognostic biomarker with molecular and clinical implications"],"prefix":"10.1186","volume":"162","author":[{"given":"Xiaofen","family":"Wen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianling","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Didi","family":"Xi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minna","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"De","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenwu","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danxia","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaxin","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,18]]},"reference":[{"issue":"1","key":"476_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, et al. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17\u201348.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"476_CR2","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13045-021-01121-2","volume":"14","author":"U Majeed","year":"2021","unstructured":"Majeed U, et al. Targeted therapy in advanced non-small cell lung cancer: current advances and future trends. J Hematol Oncol. 2021;14(1):108.","journal-title":"J Hematol Oncol"},{"issue":"3","key":"476_CR3","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1158\/2159-8290.CD-21-0212","volume":"12","author":"D Plana","year":"2022","unstructured":"Plana D, Palmer AC, Sorger PK. Independent Drug Action in Combination Therapy: Implications for Precision Oncology. Cancer Discov. 2022;12(3):606\u201324.","journal-title":"Cancer Discov"},{"issue":"15","key":"476_CR4","doi-asserted-by":"publisher","first-page":"4592","DOI":"10.1158\/1078-0432.CCR-18-1538","volume":"25","author":"DB Doroshow","year":"2019","unstructured":"Doroshow DB, et al. Immunotherapy in Non-Small Cell Lung Cancer: Facts and Hopes. Clin Cancer Res. 2019;25(15):4592\u2013602.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"476_CR5","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1200\/JCO.21.01626","volume":"40","author":"AC Tan","year":"2022","unstructured":"Tan AC, Tan DSW. Targeted Therapies for Lung Cancer Patients With Oncogenic Driver Molecular Alterations. J Clin Oncol. 2022;40(6):611\u201325.","journal-title":"J Clin Oncol"},{"issue":"8","key":"476_CR6","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1093\/annonc\/mdz167","volume":"30","author":"J Mazieres","year":"2019","unstructured":"Mazieres J, et al. Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry. Ann Oncol. 2019;30(8):1321\u20138.","journal-title":"Ann Oncol"},{"issue":"3","key":"476_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2021.100124","volume":"6","author":"A Galvano","year":"2021","unstructured":"Galvano A, et al. The prognostic impact of tumor mutational burden (TMB) in the first-line management of advanced non-oncogene addicted non-small-cell lung cancer (NSCLC): a systematic review and meta-analysis of randomized controlled trials. ESMO Open. 2021;6(3): 100124.","journal-title":"ESMO Open"},{"issue":"2","key":"476_CR8","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1056\/NEJMra1703481","volume":"378","author":"MA Postow","year":"2018","unstructured":"Postow MA, Sidlow R, Hellmann MD. Immune-Related Adverse Events Associated with Immune Checkpoint Blockade. N Engl J Med. 2018;378(2):158\u201368.","journal-title":"N Engl J Med"},{"issue":"1","key":"476_CR9","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/s41420-023-01416-y","volume":"9","author":"Z He","year":"2023","unstructured":"He Z, He J, Xie K. KLF4 transcription factor in tumorigenesis. Cell Death Discov. 2023;9(1):118.","journal-title":"Cell Death Discov"},{"issue":"2","key":"476_CR10","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1074\/jbc.273.2.1026","volume":"273","author":"SF Yet","year":"1998","unstructured":"Yet SF, et al. Human EZF, a Kr\u00fcppel-like zinc finger protein, is expressed in vascular endothelial cells and contains transcriptional activation and repression domains. J Biol Chem. 1998;273(2):1026\u201331.","journal-title":"J Biol Chem"},{"issue":"1","key":"476_CR11","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s12885-022-09198-9","volume":"22","author":"X Luo","year":"2022","unstructured":"Luo X, et al. Prognostic significance of KLF4 in solid tumours: an updated meta-analysis. BMC Cancer. 2022;22(1):181.","journal-title":"BMC Cancer"},{"issue":"12","key":"476_CR12","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550.","journal-title":"Genome Biol"},{"issue":"1","key":"476_CR13","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26(1):139\u201340.","journal-title":"Bioinformatics"},{"issue":"10","key":"476_CR14","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1093\/bioinformatics\/btt138","volume":"29","author":"S Lotia","year":"2013","unstructured":"Lotia S, et al. Cytoscape app store. Bioinformatics. 2013;29(10):1350\u20131.","journal-title":"Bioinformatics"},{"key":"476_CR15","doi-asserted-by":"crossref","unstructured":"Chin, C.H., et al., cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol, 2014. 8 Suppl 4(Suppl 4): p. S11.","DOI":"10.1186\/1752-0509-8-S4-S11"},{"issue":"5","key":"476_CR16","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, et al. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284\u20137.","journal-title":"OMICS"},{"issue":"43","key":"476_CR17","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"476_CR18","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 2013;14:7.","journal-title":"BMC Bioinformatics"},{"issue":"4","key":"476_CR19","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.immuni.2013.10.003","volume":"39","author":"G Bindea","year":"2013","unstructured":"Bindea G, et al. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity. 2013;39(4):782\u201395.","journal-title":"Immunity"},{"issue":"21","key":"476_CR20","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","volume":"77","author":"T Li","year":"2017","unstructured":"Li T, et al. TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells. Cancer Res. 2017;77(21):e108\u201310.","journal-title":"Cancer Res"},{"key":"476_CR21","doi-asserted-by":"crossref","unstructured":"Li, T., et al., TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res, 2020. 48(W1): p. W509-w514.","DOI":"10.1093\/nar\/gkaa407"},{"issue":"4","key":"476_CR22","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","volume":"48","author":"V Thorsson","year":"2018","unstructured":"Thorsson V, et al. The Immune Landscape of Cancer. Immunity. 2018;48(4):812-830.e14.","journal-title":"Immunity"},{"key":"476_CR23","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.neo.2022.01.001","volume":"25","author":"DS Chandrashekar","year":"2022","unstructured":"Chandrashekar DS, et al. UALCAN: An update to the integrated cancer data analysis platform. Neoplasia. 2022;25:18\u201327.","journal-title":"Neoplasia"},{"issue":"8","key":"476_CR24","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","volume":"19","author":"DS Chandrashekar","year":"2017","unstructured":"Chandrashekar DS, et al. UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses. Neoplasia. 2017;19(8):649\u201358.","journal-title":"Neoplasia"},{"issue":"3","key":"476_CR25","doi-asserted-by":"publisher","first-page":"277","DOI":"10.2217\/epi-2017-0118","volume":"10","author":"V Modhukur","year":"2018","unstructured":"Modhukur V, et al. MethSurv: a web tool to perform multivariable survival analysis using DNA methylation data. Epigenomics. 2018;10(3):277\u201388.","journal-title":"Epigenomics"},{"issue":"1","key":"476_CR26","doi-asserted-by":"publisher","first-page":"2226353","DOI":"10.1080\/15384047.2023.2226353","volume":"24","author":"Y Zheng","year":"2023","unstructured":"Zheng Y, et al. KLF4 targets RAB26 and decreases 5-FU resistance through inhibiting autophagy in colon cancer. Cancer Biol Ther. 2023;24(1):2226353.","journal-title":"Cancer Biol Ther"},{"key":"476_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2022.101396","volume":"22","author":"DD Luo","year":"2022","unstructured":"Luo DD, Zhao F. KLF4 suppresses the proliferation and metastasis of NSCLC cells via inhibition of MSI2 and regulation of the JAK\/STAT3 signaling pathway. Transl Oncol. 2022;22: 101396.","journal-title":"Transl Oncol"},{"issue":"4","key":"476_CR28","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41419-020-2479-z","volume":"11","author":"Y Li","year":"2020","unstructured":"Li Y, et al. KLF4-mediated upregulation of CD9 and CD81 suppresses hepatocellular carcinoma development via JNK signaling. Cell Death Dis. 2020;11(4):299.","journal-title":"Cell Death Dis"},{"issue":"5","key":"476_CR29","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.stemcr.2020.03.025","volume":"14","author":"Y Li","year":"2020","unstructured":"Li Y, et al. Inhibition of KLF4 by Statins Reverses Adriamycin-Induced Metastasis and Cancer Stemness in Osteosarcoma Cells. Stem Cell Reports. 2020;14(5):989\u201390.","journal-title":"Stem Cell Reports"},{"key":"476_CR30","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.canlet.2019.09.012","volume":"467","author":"H Zou","year":"2019","unstructured":"Zou H, et al. ATXN3 promotes breast cancer metastasis by deubiquitinating KLF4. Cancer Lett. 2019;467:19\u201328.","journal-title":"Cancer Lett"},{"issue":"1","key":"476_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0054806","volume":"8","author":"JC Jean","year":"2013","unstructured":"Jean JC, et al. Transcription factor Klf4, induced in the lung by oxygen at birth, regulates perinatal fibroblast and myofibroblast differentiation. PLoS ONE. 2013;8(1): e54806.","journal-title":"PLoS ONE"},{"issue":"2","key":"476_CR32","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/cdd.2015.85","volume":"23","author":"T Yu","year":"2016","unstructured":"Yu T, et al. KLF4 regulates adult lung tumor-initiating cells and represses K-Ras-mediated lung cancer. Cell Death Differ. 2016;23(2):207\u201315.","journal-title":"Cell Death Differ"},{"issue":"2","key":"476_CR33","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s11010-020-03959-5","volume":"476","author":"Y Wang","year":"2021","unstructured":"Wang Y, et al. Identification of key genes and biological pathways in lung adenocarcinoma via bioinformatics analysis. Mol Cell Biochem. 2021;476(2):931\u20139.","journal-title":"Mol Cell Biochem"},{"issue":"9","key":"476_CR34","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/nrg887","volume":"3","author":"E Li","year":"2002","unstructured":"Li E. Chromatin modification and epigenetic reprogramming in mammalian development. Nat Rev Genet. 2002;3(9):662\u201373.","journal-title":"Nat Rev Genet"},{"key":"476_CR35","doi-asserted-by":"publisher","unstructured":"Yang L, He YT, Dong S, Wei XW, Chen ZH, Zhang B, Chen WD, Yang XR, Wang F, Shang XM, Zhong WZ, Wu YL, Zhou Q. Single-cell transcriptome analysis revealed a suppressive tumor immune microenvironment in EGFR mutant lung adenocarcinoma. J Immunother Cancer. 2022;10(2):e003534. https:\/\/doi.org\/10.1136\/jitc-2021-003534. PMID: 35140113; PMCID: PMC8830346.","DOI":"10.1136\/jitc-2021-003534"},{"issue":"24","key":"476_CR36","doi-asserted-by":"publisher","first-page":"6450","DOI":"10.1182\/blood-2011-06-363713","volume":"118","author":"AK Wara","year":"2011","unstructured":"Wara AK, et al. TGF-\u03b21 signaling and Kr\u00fcppel-like factor 10 regulate bone marrow-derived proangiogenic cell differentiation, function, and neovascularization. Blood. 2011;118(24):6450\u201360.","journal-title":"Blood"},{"issue":"2\u20133","key":"476_CR37","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s12026-014-8517-0","volume":"58","author":"FS Dhabhar","year":"2014","unstructured":"Dhabhar FS. Effects of stress on immune function: the good, the bad, and the beautiful. Immunol Res. 2014;58(2\u20133):193\u2013210.","journal-title":"Immunol Res"},{"key":"476_CR38","doi-asserted-by":"publisher","unstructured":"Arora S, Singh P, Ahmad S, Ahmad T, Dohare R, Almatroodi SA, Alrumaihi F, Rahmani AH, Syed MA. Comprehensive integrative analysis reveals the association of KLF4 with macrophage infiltration and polarization in lung cancer microenvironment. Cells. 2021;10(8):2091. https:\/\/doi.org\/10.3390\/cells10082091. PMID: 34440860; PMCID: PMC8392240.","DOI":"10.3390\/cells10082091"},{"key":"476_CR39","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.biopha.2018.01.090","volume":"99","author":"M Liu","year":"2018","unstructured":"Liu M, et al. Subcellular localization of Klf4 in non-small cell lung cancer and its clinical significance. Biomed Pharmacother. 2018;99:480\u20135.","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"476_CR40","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1038\/s41418-019-0458-7","volume":"27","author":"X Wang","year":"2020","unstructured":"Wang X, et al. The deubiquitinase USP10 regulates KLF4 stability and suppresses lung tumorigenesis. Cell Death Differ. 2020;27(6):1747\u201364.","journal-title":"Cell Death Differ"}],"container-title":["Hereditas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-025-00476-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41065-025-00476-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-025-00476-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T06:15:52Z","timestamp":1750227352000},"score":1,"resource":{"primary":{"URL":"https:\/\/hereditasjournal.biomedcentral.com\/articles\/10.1186\/s41065-025-00476-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,18]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["476"],"URL":"https:\/\/doi.org\/10.1186\/s41065-025-00476-7","relation":{},"ISSN":["1601-5223"],"issn-type":[{"value":"1601-5223","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,18]]},"assertion":[{"value":"7 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Institutional Review Board Statement: The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of Cancer Hospital of Shantou University (Approval Number: 2021042).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors consent to the publication of this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"106"}}